Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katelynn Granger"'
Autor:
Kevin C. Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J. Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 793-797 (2024)
Abstract Teclistamab is a B‐cell maturation antigen (BCMA)‐directed bispecific T‐cell engager approved for relapsed‐refractory multiple myeloma (RRMM). Cytokine release syndrome (CRS) and Immune effector cell‐associated neurotoxicity syndro
Externí odkaz:
https://doaj.org/article/52d53d0c9d374fbfa2c3a623e2dafa7c
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:722-726
Objective Summarize the background, clinical trials, and place in therapy for the newly Food and Drug Administration (FDA) approved and forthcoming bispecific antibodies for relapsed/refractory (R/R) multiple myeloma. Data Sources A search of the Pub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be473cef61779282958b2b859c3db7f9
https://doi.org/10.1177/10781552231154809
https://doi.org/10.1177/10781552231154809
Autor:
Kelly Gaffney, Jonathan Bakos, Arash Velayati, James Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, Deidra Smith, Kimberly Green, Brian Hess, Hamza Hashmi
Introduction: High-dose chemotherapy-autologous stem cell transplant (HDT-ASCT) improves both depth and duration of remission for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM). Whether certain subgroups of NDMM derive the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f42004f4cd6aaf19fb4100c8cec3c31
https://doi.org/10.21203/rs.3.rs-2886938/v1
https://doi.org/10.21203/rs.3.rs-2886938/v1
Autor:
James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Publikováno v:
Blood.
COVID-19 still represents a major issue for patients with lymphoid malignancies, especially those on therapy, because of immune suppression and suboptimal responses to vaccination. Davis et al report on their experience with double dose tixagevimab-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c9658555999e1f1c67e4a7310763dc
https://pubmed.ncbi.nlm.nih.gov/36332185
https://pubmed.ncbi.nlm.nih.gov/36332185
Autor:
Arash Velayati, Mary McGann, Kiera Roubal, Katelynn Granger, James A Davis, Kelly Gaffney, Erin Weeda, Mr. Hamza Hashmi
Publikováno v:
Transplantation and Cellular Therapy. 29:S201-S202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e09d72363a5e504c3f0d819d3b10fb29
https://doi.org/10.1016/s2666-6367(23)00330-5
https://doi.org/10.1016/s2666-6367(23)00330-5
Publikováno v:
Blood. 140:12764-12765
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::808f16d558991aede01250a4049286ef
https://doi.org/10.1182/blood-2022-164729
https://doi.org/10.1182/blood-2022-164729
Autor:
Ryan M. Vesper, Lauren Kemp, Prashanth Iyer, Katelynn Granger, Christina T. Doligalski, Mirnela Byku, Ian B. Hollis
Publikováno v:
Journal of Pharmacy Practice. :089719002211275
Background While guidelines suggest intravenous (IV) iron to improve functional status and quality of life (QoL) in patients with NYHA class II-III heart failure (HF), continuous flow left ventricular assist device (CF-LVAD) recipients were not inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cdc59f4d4d809a621256dc2c5f1f3f
https://doi.org/10.1177/08971900221127500
https://doi.org/10.1177/08971900221127500